Laura Dyball

About

Laura’s PhD focuses on the ‘Development of New Vaccine Manufacturing Platforms’. The project will investigate and produce new and modified cell expression technologies for the manufacturing of vaccines with the aim of developing platforms for the production of cheap, rapid and high quality vaccines. The vaccines will target Dengue fever and other diseases relevant to GCRF countries. Laura has a BSc in Applied Biology and an MSc in Biotechnology from Northumbria University, as well as professional experience within NHS Blood Sciences laboratories.

Supervision

Professor Mark Smales and Professor Colin Robinson, School of Biosciences.